| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| COMPASS Pathways plc | Director | Ordinary Shares | 19,480 | $134,022 | $6.88 | 01 Aug 2024 | Direct |
| Mereo BioPharma Group plc | Director | Share Options (Right to buy) | 66,000 | $55,550 | $1.01 | 26 Feb 2026 | Direct |
| Mereo BioPharma Group plc | Director | Deferred Restricted Stock Units | 106,848 | 26 Feb 2026 | Direct | ||
| AgeX Therapeutics, Inc. | Director | Option to Purchase Common Stock | 65,000 | 21 Jun 2021 | Direct | ||
| Skye Bioscience, Inc. | Director | Stock Option (Right to Buy) | 35,000 | 06 Feb 2026 | Direct | ||
| COMPASS Pathways plc | Director | Share Option (Right to Buy) | 26,000 | 12 Jun 2025 | Direct | ||
| AVROBIO, Inc. | Director | Stock Option (Right to Buy) | 17,643 | 06 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MREO | Mereo BioPharma Group plc | 26 Feb 2026 | 2 | $0 | 4 | Director | 27 Feb 2026, 16:30 |
| SKYE | Skye Bioscience, Inc. | 06 Feb 2026 | 1 | $0 | 4 | Director | 09 Feb 2026, 20:54 |
| CMPS | COMPASS Pathways plc | 12 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 08:16 |
| SKYE | Skye Bioscience, Inc. | 24 Feb 2025 | 1 | $0 | 4 | Director | 26 Feb 2025, 17:51 |
| MREO | Mereo BioPharma Group plc | 05 Feb 2025 | 2 | $0 | 4 | Director | 06 Feb 2025, 16:30 |
| SKYE | Skye Bioscience, Inc. | 28 Oct 2024 | 1 | $0 | 4 | Director | 30 Oct 2024, 20:25 |
| CMPS | COMPASS Pathways plc | 01 Aug 2024 | 1 | -$1,108 | 4 | Director | 05 Aug 2024, 08:28 |
| CMPS | COMPASS Pathways plc | 09 May 2024 | 1 | $0 | 4 | Director | 13 May 2024, 06:45 |
| CMPS | COMPASS Pathways plc | 01 May 2024 | 1 | -$1,789 | 4 | Director | 03 May 2024, 08:13 |
| SKYE | Skye Bioscience, Inc. | 29 Feb 2024 | 1 | $0 | 4 | Director | 04 Mar 2024, 18:01 |
| SKYE | Skye Bioscience, Inc. | 29 Feb 2024 | 0 | $0 | 3 | Director | 04 Mar 2024, 16:18 |
| MREO | Mereo BioPharma Group plc | 08 Feb 2024 | 2 | $0 | 4 | Director | 09 Feb 2024, 16:15 |
| CMPS | COMPASS Pathways plc | 01 Feb 2024 | 1 | -$1,984 | 4 | Director | 05 Feb 2024, 17:10 |
| MREO | Mereo Biopharma Group plc | 01 Jan 2024 | 0 | $0 | 3 | Director | 02 Jan 2024, 16:15 |
| CMPS | COMPASS Pathways plc | 01 Nov 2023 | 1 | -$827 | 4 | Director | 02 Nov 2023, 09:06 |
| CMPS | COMPASS Pathways plc | 01 Aug 2023 | 1 | -$1,441 | 4 | Director | 03 Aug 2023, 18:50 |
| TECX | AVROBIO, Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 16:26 |
| CMPS | COMPASS Pathways plc | 02 Jun 2023 | 1 | $0 | 4 | Director | 06 Jun 2023, 16:23 |
| CMPS | COMPASS Pathways plc | 02 May 2023 | 1 | -$199 | 4 | Director | 04 May 2023, 08:25 |
| CMPS | COMPASS Pathways plc | 16 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:08 |
| TECX | AVROBIO, Inc. | 08 Jun 2022 | 2 | $0 | 4 | Director | 10 Jun 2022, 16:38 |
| CMPS | COMPASS Pathways plc | 29 Mar 2022 | 1 | -$42,232 | 4 | Director | 31 Mar 2022, 14:09 |
| CMPS | COMPASS Pathways plc | 01 Jan 2022 | 0 | $0 | 3 | Director | 03 Jan 2022, 15:17 |
| SER | AgeX Therapeutics, Inc. | 21 Jun 2021 | 1 | $0 | 4 | Director | 23 Jun 2021, 21:50 |
| TECX | AVROBIO, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 17:40 |